---
category: news
title: "Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China"
excerpt: "Epizyme, Inc. (\"Epizyme\") , a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, and HUTCHMED (China) Limited (\"HUTCHMED\") , today announce a collaboration to research,"
publishedDateTime: 2021-08-09T00:11:00Z
originalUrl: "https://www.lelezard.com/en/news-19941174.html"
webUrl: "https://www.lelezard.com/en/news-19941174.html"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Le Lézard
  domain: lelezard.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.lelezard.com/img/pr_sections/health.jpg"
    width: 640
    height: 480
    isCached: true

secured: "vNwCnmL56knb9H4CpkROeLTdx06rxO0ANPkeGP4AT+lPOrYhGpc5qAqMy6VV8hZqqr76e6k7eECmsv3afGsavOaPPXRmti6eHPa/KQOC1R3y4rUdjyy4JP+T5z7o8ov8ZDvYDZU/BLWZotfuDDiEztIJeY+DARwX0VXBxig+vusrEEPQR042x9QTrlU1jPwGFLmzj/A7V8405JsVMpccqzxdSKU9ZqKpy5ncqejs74QfDqFzbIzRvrcTtXrf9dRJ4Rs+rEP56E11b9vWCGNo1habQVOO53lsgNZVEAkSm+iRS5GMnLtwpObeyH1r7V+gQ3UQ4WKm/B5T9jNqqmoM7+SBIm0EH+EE/KAny5WCnYg=;7++/q5Muw4nbpt/u6jm6fg=="
---

